The petition contends that separate state-level investigations have led to fragmented accountability, enabling repeated lapses that allow hazardous formulations to reach the market.
Related Posts
US regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps
Post Views: 15 Federal agencies could consider restrictions on how…

Rare but ruthless: How a deadly amoeba is claiming lives in Kerala
Post Views: 13 Kerala Health Minister Veena George told the…
No cashless claim for Tata AIG health insurance policyholders in Max Hospitals, becomes 3rd insurer to do so
Post Views: 11 Tata AIG suspended cashless services at Max…